Our study confirmed that the abnormally elevated expression of NUSAP1 was closely related to the progression of NAFLD patients from no-fibrosis to fibrosis, and even to HCC, indicating that their antagonism may inhibit or delay the process of NAFLD to HCC. This evidence concerns the gene NUSAP1 and hepatocellular carcinoma.